CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-19 | Peraza Lisa VP, Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +41,078 | 41,078 | ||
| 2024-01-19 | Peraza Lisa VP, Chief Accounting Officer | Grant or award · Restricted Stock Units | +6,846 | 6,846 | ||
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion | +552 | 55,374 | ||
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion | +1,289 | 56,663 | ||
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −756 | $2.15 | $2K | 55,907 |
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −552 | 1,656 | ||
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −1,289 | 6,675 | ||
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion | +552 | 53,750 | ||
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion | +1,932 | 55,682 | ||
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −860 | $0.72 | $619 | 54,822 |
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −552 | 2,208 | ||
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −1,932 | 7,964 | ||
| 2023-07-25 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion | +42,631 | 67,941 | ||
| 2023-07-25 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −14,743 | $1.51 | $22K | 53,198 |
| 2023-07-25 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion · Performance Stock Units | −42,631 | 0 | ||
| 2023-07-17 | Peraza Lisa VP, Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-07-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion | +552 | 24,237 | ||
| 2023-07-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion | +1,933 | 26,170 | ||
| 2023-07-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −860 | $1.31 | $1K | 25,310 |
| 2023-07-13 | Peraza Lisa VP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −552 | 2,760 |
Page 1 of 4 · 70 trades